VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The Company”, a leader in the development, formulation, and manufacturing of ...
VANCOUVER, BC / ACCESSWIRE / May 1, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce that its wholly-owned subsidiaries ...
The health ministry is unlikely to extend the Schedule M deadline for MSME pharma firms beyond December 31, 2025, as it ...
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the good ...
The Union Health Ministry is holding discussions with state governments and drug regulatory authorities to consider granting ...
Hosted on MSN
A disgraced former Wigan police officer jailed for drug dealing is ordered to pay up £75k in ill-gotten gains
Andrew Talbot, 55, who was previously a Greater Manchester Police (GMP) detective working within the force’s Serious Crime Division, stole just under 4kg of cocaine from the GMP property store at ...
Applied StemCell, an advanced therapeutics CRO/CDMO specializing in iPSCs, gene editing, and small animal models, announced today that it has submitted a Type II Drug Master File (DMF) to the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback